What is Synchrony Labs?
Founded over 40 years ago by Duke University Medical School cardiology leaders, Synchrony Labs specializes in expert preclinical medical device testing and regulatory consulting. The company offers GLP-compliant studies and crucial FDA approval support, serving clients in the medical device and pharmaceutical industries. Its seasoned team of veterinarians, physicians, and data scientists is committed to advancing life-changing medical science through innovative preclinical trials, emphasizing data integrity, clear communication, and collaboration to guide innovations from preclinical to clinical phases.
How much funding has Synchrony Labs raised?
Synchrony Labs has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Synchrony Labs?
The recent large-scale, late-stage funding context suggests Synchrony Labs is poised for significant expansion and further entrenchment in its market. This strategic investment will likely fuel advancements in its service offerings, potentially broadening its scope of preclinical testing capabilities or enhancing its regulatory consulting expertise. The company's long-standing history and focus on data integrity position it for continued leadership and innovation in supporting the development of novel medical devices and pharmaceuticals.
See full Synchrony Labs company page
